Anterior Segment Company Showcase - Envisia Therapeutics

14

Transcript of Anterior Segment Company Showcase - Envisia Therapeutics

Page 1: Anterior Segment Company Showcase - Envisia Therapeutics
Page 2: Anterior Segment Company Showcase - Envisia Therapeutics
Page 3: Anterior Segment Company Showcase - Envisia Therapeutics
Page 4: Anterior Segment Company Showcase - Envisia Therapeutics
Page 5: Anterior Segment Company Showcase - Envisia Therapeutics
Page 6: Anterior Segment Company Showcase - Envisia Therapeutics
Page 7: Anterior Segment Company Showcase - Envisia Therapeutics
Page 8: Anterior Segment Company Showcase - Envisia Therapeutics
Page 9: Anterior Segment Company Showcase - Envisia Therapeutics
Page 10: Anterior Segment Company Showcase - Envisia Therapeutics
Page 11: Anterior Segment Company Showcase - Envisia Therapeutics
Page 12: Anterior Segment Company Showcase - Envisia Therapeutics
Page 13: Anterior Segment Company Showcase - Envisia Therapeutics
Page 14: Anterior Segment Company Showcase - Envisia Therapeutics

Asthma therapeutics

Asthma therapeutics

Nano Therapeutics

Nano Therapeutics

BIOTECH FINANCING SUMMARY October 201 4 · Argos Therapeutics, Inc. Therapeutics / Diagnostics Tetra Discovery Partners Therapeutics / Diagnostics Allakos Inc. Therapeutics / Diagnostics

BIOTECH FINANCING SUMMARY October 201 4 · Argos Therapeutics, Inc. Therapeutics / Diagnostics Tetra Discovery Partners Therapeutics / Diagnostics Allakos Inc. Therapeutics / Diagnostics

ENVISIA - boral.com.au

ENVISIA - boral.com.au

Are Eye Drops Dead?...(Envisia Therapeutics) Biodegradable implant (anterior chamber) Dose-Ranging Phase II 6 –12 months BimatoprostOcular Insert •Simple, non-invasive ocular insert

Are Eye Drops Dead?...(Envisia Therapeutics) Biodegradable implant (anterior chamber) Dose-Ranging Phase II 6 –12 months BimatoprostOcular Insert •Simple, non-invasive ocular insert

Envisia Learning

Envisia Learning

Ocular Therapeutics

Ocular Therapeutics

Ocular therapeutics

Ocular therapeutics

1047 GR ONdrugDelivery Issue 48 Opthalmic Mar 14...Envisia Therapeutics, Inc 16 - 18 Breakthrough Nanotechnology Enhances Delivery to the Front and Back of the Eye Dr Hongming Chen,

1047 GR ONdrugDelivery Issue 48 Opthalmic Mar 14...Envisia Therapeutics, Inc 16 - 18 Breakthrough Nanotechnology Enhances Delivery to the Front and Back of the Eye Dr Hongming Chen,

Things Everyone Should Know About the NCSU Libraries · Envisia Therapeutics Fujifilm GE Hitachi Nuclear Energy Glen Raven, Inc. Gnarus Advisors LLC GrassRoots Biotechnology, Inc.

Things Everyone Should Know About the NCSU Libraries · Envisia Therapeutics Fujifilm GE Hitachi Nuclear Energy Glen Raven, Inc. Gnarus Advisors LLC GrassRoots Biotechnology, Inc.

Pharmacology & Therapeutics

Pharmacology & Therapeutics

microRNA therapeutics

microRNA therapeutics

Protein Therapeutics

Protein Therapeutics

Digital Therapeutics

Digital Therapeutics

Biotech Showcase 2013 Conference - Issuer Directedg1.precisionir.com/companyspotlight/NA016283/...2013 Cardium Therapeutics, Inc. Forward Looking Statements This presentation may contain

Biotech Showcase 2013 Conference - Issuer Directedg1.precisionir.com/companyspotlight/NA016283/...2013 Cardium Therapeutics, Inc. Forward Looking Statements This presentation may contain

Envisia Therapeutics

Envisia Therapeutics

Cell Therapeutics

Cell Therapeutics

Medikamente: Was gibt es ? Was kommt in naher Zukunft• Travoprost –intracamerales Implant (ENV515, Envisia Therapeutics) • Phase II b: 6,7 mmHg IOD –Senkung (28%) nach 25 Tagen

Medikamente: Was gibt es ? Was kommt in naher Zukunft• Travoprost –intracamerales Implant (ENV515, Envisia Therapeutics) • Phase II b: 6,7 mmHg IOD –Senkung (28%) nach 25 Tagen

Facilitation Manual (Self-Assessment) - Envisia Learning

Facilitation Manual (Self-Assessment) - Envisia Learning

Nucleic Acid Therapeutics 1 Nucleic Acid Therapeutics: Current Targets For Antisense ... · 2016-01-28 · Nucleic Acid Therapeutics 1 Nucleic Acid Therapeutics: Current Targets For

Nucleic Acid Therapeutics 1 Nucleic Acid Therapeutics: Current Targets For Antisense ... · 2016-01-28 · Nucleic Acid Therapeutics 1 Nucleic Acid Therapeutics: Current Targets For